Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

334 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
HIGH-DOSE CHEMOTHERAPY FOR MULTIPLY OR POOR-RISK RELAPSED GERM-CELL TUMORS.
Nieto Y, Ward JF, Hofstetter W, Rice D, Karam JA, Pisters L, Vauthey JN, Shah A, Lin JK, Johns AC, Araujo J, Tu SM, Wang J, Li J, Abudayyeh A, Thall PF, Bassett R, Barnett M, Gulbis A, Shigle TL, Ramdial J, Popat U, Qazilbash M, Jones RB, Andersson BS, Shpall EJ, Sheikh I, Pagliaro L, Campbell MT. Nieto Y, et al. Among authors: qazilbash m. Clin Cancer Res. 2025 Aug 25. doi: 10.1158/1078-0432.CCR-25-1917. Online ahead of print. Clin Cancer Res. 2025. PMID: 40853903
Author Correction: Clonal evolution of hematopoietic stem cells after autologous stem cell transplantation.
Uryu H, Saeki K, Haeno H, Kapadia CD, Furudate K, Nangalia J, Spencer Chapman M, Zhang L, Padilla J, Zhao L, Hsu JI, Zhao C, Chen S, Tanaka T, Li Z, Ogata S, Hanache S, Yang H, DiNardo C, Daver N, Pemmaraju N, Jain N, Ravandi F, Zhang J, Song X, Thompson E, Tang H, Little L, Gumbs C, Orlowski RZ, Qazilbash M, Bhalla K, Colla S, Kantarjian H, Kanagal-Shamanna R, Bueso-Ramos C, Nakada D, Al-Atrash G, Molldrem J, Futreal PA, Shpall E, Goodell M, Garcia-Manero G, Takahashi K. Uryu H, et al. Among authors: qazilbash m. Nat Genet. 2025 Sep;57(9):2339. doi: 10.1038/s41588-025-02328-6. Nat Genet. 2025. PMID: 40789920 Free PMC article. No abstract available.
Outcomes of Patients With Multiple Myeloma With deletion 1p Following Autologous Stem Cell Transplant.
Marcoux C, Milton DR, Tanner MR, Bashir Q, Srour S, Saini N, Lin P, Patel A, Khan HN, Ramdial J, Nieto Y, Tang G, Haider A, Aljawai Y, Kebriaei P, Lee HC, Ye C, Patel KK, Thomas SK, Orlowski RZ, Champlin RE, Shpall EJ, Qazilbash MH, Pasvolsky O. Marcoux C, et al. Among authors: qazilbash mh. Transplant Cell Ther. 2025 Aug 5:S2666-6367(25)01336-3. doi: 10.1016/j.jtct.2025.07.023. Online ahead of print. Transplant Cell Ther. 2025. PMID: 40752590
Tagraxofusp maintenance post-hematopoietic stem cell transplantation provides long-term survival and manageable safety for a patient with blastic plasmacytoid dendritic cell neoplasm.
Bashir Q, Konopleva M, Abueg G, Ramdial J, Hosing C, Srour SA, Alousi A, Popat UR, Nieto Y, Alatrash G, Champlin RE, Shpall EJ, Qazilbash M, Pemmaraju N. Bashir Q, et al. Among authors: qazilbash m. Leuk Res Rep. 2025 Jun 12;24:100518. doi: 10.1016/j.lrr.2025.100518. eCollection 2025. Leuk Res Rep. 2025. PMID: 40612021 Free PMC article.
Clonal evolution of hematopoietic stem cells after autologous stem cell transplantation.
Uryu H, Saeki K, Haeno H, Kapadia CD, Furudate K, Nangalia J, Spencer Chapman M, Zhang L, Padilla J, Zhao L, Hsu JI, Zhao C, Chen S, Tanaka T, Li Z, Ogata S, Hanache S, Yang H, DiNardo C, Daver N, Pemmaraju N, Jain N, Ravandi F, Zhang J, Song X, Thompson E, Tang H, Little L, Gumbs C, Orlowski RZ, Qazilbash M, Bhalla K, Colla S, Kantarjian H, Kanagal-Shamanna R, Bueso-Ramos C, Nakada D, Al-Atrash G, Molldrem J, Futreal PA, Shpall E, Goodell M, Garcia-Manero G, Takahashi K. Uryu H, et al. Among authors: qazilbash m. Nat Genet. 2025 Jul;57(7):1695-1707. doi: 10.1038/s41588-025-02235-w. Epub 2025 Jul 1. Nat Genet. 2025. PMID: 40596442 Free PMC article.
Author Correction: Allogeneic NK cells with a bispecific innate cell engager in refractory relapsed lymphoma: a phase 1 trial.
Nieto Y, Banerjee P, Kaur I, Basar R, Li Y, Daher M, Rafei H, Kerbauy LN, Kaplan M, Marin D, Griffin L, Barnett M, Bassett R, Uprety N, Shrestha R, Silva FR, Islam S, Ganesh C, Borneo Z, Ramdial J, Ramirez A, Hosing C, Alousi A, Popat U, Qazilbash M, Ahmed S, Iyer S, Sainz TP, Vega F, Fowlkes NW, Alexis K, Emig M, Harstrick A, Overesch A, Shpall EJ, Rezvani K. Nieto Y, et al. Among authors: qazilbash m. Nat Med. 2025 Aug;31(8):2816. doi: 10.1038/s41591-025-03852-y. Nat Med. 2025. PMID: 40571757 No abstract available.
Outcomes of Multiple Myeloma Patients With Prior Solid Tumors Undergoing Autologous Transplantation.
Pasvolsky O, Marcoux C, Milton DR, Rafaeli N, Tanner MR, Bashir Q, Srour S, Saini N, Lin P, Ramdial J, Nieto Y, Tang G, Mohamedi AH, Deen AF, Aljawai Y, Lee HC, Patel KK, Becnel MR, Kebriaei P, Thomas SK, Orlowski RZ, Champlin R, Shpall EJ, Qazilbash MH. Pasvolsky O, et al. Among authors: qazilbash mh. Transplant Cell Ther. 2025 Aug;31(8):565.e1-565.e9. doi: 10.1016/j.jtct.2025.05.008. Epub 2025 May 16. Transplant Cell Ther. 2025. PMID: 40383197
The Impact of Melphalan Conditioning and CD34 + Cell Dose and Schedule on Post-Transplant Outcomes in AL Amyloidosis.
Muchtar E, Sanchorawala V, Hassan H, Hegenbart U, Schönland S, Lee HC, Qazilbash M, Kin A, Zonder J, Jacob E, Buadi F, Dispenzieri A, Dingli D, Arai S, Chin M, Chakraborty R, Lentzsch S, Magen H, Shkury E, Sarubbi C, Landau H, Gertz M. Muchtar E, et al. Among authors: qazilbash m. Am J Hematol. 2025 Jul;100(7):1141-1151. doi: 10.1002/ajh.27685. Epub 2025 Apr 11. Am J Hematol. 2025. PMID: 40214172
334 results